# GCB-002 in Treatment of Patients With Rett Syndrome

> **NCT06739434** · NA · ENROLLING_BY_INVITATION · sponsor: **Genecombio Ltd.** · enrollment: 6 (estimated)

## Conditions studied

- RETT Syndrome With Proven MECP2 Mutation

## Interventions

- **GENETIC:** GCB-002

## Key facts

- **NCT ID:** NCT06739434
- **Lead sponsor:** Genecombio Ltd.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-11-11
- **Primary completion:** 2026-12
- **Final completion:** 2030-12
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06739434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06739434, "GCB-002 in Treatment of Patients With Rett Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06739434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*